John B. Ketchum
At a glance: John B. Ketchum is Director at Tango Therapeutics (TNGX). Their latest SEC Form 4, filed Nov 19, 2026, reported a sale of $80K. On file: 0 purchase lines ($0) and 1 sale line ($80K).
Disclosed holdings: about $492K of TNGX stock: 21,604 shares reported on their latest Form 4 (filed Nov 19, 2026), valued at the Nov 19, 2026 close of $22.77. This counts only TNGX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Tango Therapeutics, Inc. (TNGX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 19SEC | TNGXTango Therapeutics, Inc. | Sell Plan | 3,33321,604 held (−13%) | $24.08 | $80K | -5.4% |
- Sell
Director John B Ketchum sold $80K of TNGX at $24.08 — pre-scheduled 10b5-1 plan sale.
Follow John B. Ketchum
Get one email when John B. Ketchum files a new purchase or sale. Free.
At most one email a day about John B. Ketchum, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.